TMED3
Transmembrane emp24 domain-containing protein 3
Also known as: C15orf22, p24B, p24g4, p24gamma4, TMED3_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9Y3Q3
- Gene
- TMED3
- Ensembl
- ENSG00000166557
- Chromosome
- 15
- Canonical length
- 217 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins, Transporters
- Subcellular location
- Golgi apparatus
OverviewNCBI Gene
Predicted to be involved in Golgi organization; endoplasmic reticulum to Golgi vesicle-mediated transport; and intracellular protein transport. Located in Golgi apparatus; endoplasmic reticulum; and endoplasmic reticulum-Golgi intermediate compartment. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
217 residues, UniProt reviewed canonical sequence.
>Q9Y3Q3|TMED3
1 MGSTVPRSAS VLLLLLLLRR AEQPCGAELT FELPDNAKQC FHEEVEQGVK FSLDYQVITG
61 GHYDVDCYVE DPQGNTIYRE TKKQYDSFTY RAEVKGVYQF CFSNEFSTFS HKTVYFDFQV
121 GDEPPILPDM GNRVTALTQM ESACVTIHEA LKTVIDSQTH YRLREAQDRA RAEDLNSRVS
181 YWSVGETIAL FVVSFSQVLL LKSFFTEKRP ISRAVHSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TMED3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.41
- Highest tissue expression
- 386 nTPM
Expression across tissuesHPA
Tissue
- salivary gland: 386 nTPM
- pancreas: 233 nTPM
- esophagus: 139 nTPM
- epididymis: 131 nTPM
- skin: 112 nTPM
- pituitary gland: 91 nTPM
Single-cell type
- esophageal apical cells: 1,058 nCPM
- salivary acinar cells: 684 nCPM
- esophageal suprabasal cells: 468 nCPM
- lacrimal acinar cells: 448 nCPM
- extravillous trophoblasts: 414 nCPM
- epididymal principal cells: 382 nCPM
Immune cell
- plasmacytoid DC: 109 nTPM
- myeloid DC: 107 nTPM
- non-classical monocyte: 96 nTPM
- eosinophil: 95 nTPM
- total PBMC: 92 nTPM
- intermediate monocyte: 85 nTPM
Brain region
- hypothalamus: 50 nTPM
- choroid plexus: 47 nTPM
- pons: 39 nTPM
- white matter: 36 nTPM
- medulla oblongata: 30 nTPM
- midbrain: 29 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.99
- gnomAD pLI
- 0.02
- gnomAD missense Z
- 0.3
- DepMap mean gene effect
- 0.04
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- endoplasmic reticulum to Golgi vesicle-mediated transport
- Golgi organization
- intracellular protein transport
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TMED3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TMED3 as an antibody target. Whether an autoantibody or antibody against TMED3 could matter depends on whether native TMED3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TMED3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TMED3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...